Kemp Dolliver
Stock Analyst at Brookline Capital Markets
(2.65)
# 2,992
Out of 4,453 analysts
62
Total ratings
35.9%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICCM IceCure Medical | Maintained: Buy | $83 → $74 | $7.02 | +947.01% | 7 | Jun 17, 2026 | |
| LSTA Lisata Therapeutics | Downgraded: Hold | n/a | $3.38 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgraded: Hold | n/a | $0.9354 | - | 4 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgraded: Buy | $17 | $6.21 | +173.75% | 4 | Dec 17, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $52 → $93 | $87.28 | +6.55% | 2 | Sep 25, 2025 | |
| IBIO iBio, Inc. | Reiterated: Buy | $1.6 | $1.59 | +0.63% | 3 | Sep 5, 2025 | |
| BIOX Bioceres Crop Solutions | Downgraded: Hold | $24 → $26 | $0.3251 | +7,897.54% | 8 | Aug 22, 2025 | |
| DARE Daré Bioscience | Maintained: Buy | $36 → $11 | $2.00 | +450.00% | 4 | Aug 18, 2025 | |
| RADX Radiopharm Theranostics | Initiated Coverage: Buy | $18 | $4.33 | +315.70% | 1 | Jul 21, 2025 | |
| CADL Candel Therapeutics | Initiated Coverage: Buy | $25 | $9.47 | +163.99% | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.00 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.96 | n/a | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $26 | $2.58 | n/a | 2 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31 | $1.61 | n/a | 2 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.602 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.05125 | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $109.01 | n/a | 1 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.90 | n/a | 2 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $4.5 | $0.0251 | n/a | 6 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 → $23 | $7.19 | n/a | 3 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.00001 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0056 | n/a | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.47 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.81 | n/a | 1 | Oct 20, 2022 |
IceCure Medical
Jun 17, 2026
Maintained: Buy
Price Target: $83 → $74
Current: $7.02
Upside: +947.01%
Lisata Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.38
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.9354
Upside: -
Verrica Pharmaceuticals
Dec 17, 2025
Upgraded: Buy
Price Target: $17
Current: $6.21
Upside: +173.75%
Monopar Therapeutics
Sep 25, 2025
Maintained: Buy
Price Target: $52 → $93
Current: $87.28
Upside: +6.55%
iBio, Inc.
Sep 5, 2025
Reiterated: Buy
Price Target: $1.6
Current: $1.59
Upside: +0.63%
Bioceres Crop Solutions
Aug 22, 2025
Downgraded: Hold
Price Target: $24 → $26
Current: $0.3251
Upside: +7,897.54%
Daré Bioscience
Aug 18, 2025
Maintained: Buy
Price Target: $36 → $11
Current: $2.00
Upside: +450.00%
Radiopharm Theranostics
Jul 21, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $4.33
Upside: +315.70%
Candel Therapeutics
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $9.47
Upside: +163.99%
Mar 10, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $3.00
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.96
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $150 → $26
Current: $2.58
Upside: n/a
Jan 24, 2024
Upgraded: Buy
Price Target: $31
Current: $1.61
Upside: n/a
Dec 19, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.602
Upside: n/a
Dec 7, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.05125
Upside: n/a
Nov 30, 2023
Initiated Coverage: Buy
Price Target: $100
Current: $109.01
Upside: n/a
Oct 31, 2023
Upgraded: Buy
Price Target: $25 → $30
Current: $2.90
Upside: n/a
Sep 5, 2023
Downgraded: Hold
Price Target: $7 → $4.5
Current: $0.0251
Upside: n/a
Jul 11, 2023
Initiated Coverage: Buy
Price Target: $19 → $23
Current: $7.19
Upside: n/a
May 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
May 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0056
Upside: n/a
Jan 6, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: $13
Current: $7.47
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $3.81
Upside: n/a